EUVIMEDEUVIMED entdecken
Open Access

Continuous, Week-Long, Seconds-Resolved In Vivo Drug Measurements Performed with a Xenonucleic Acid-Employing Electrochemical, Aptamer-Based Sensor

Kon Son, Jennifer M Gibson, Julian Gerson, Kaylyn K Leung, Marlaina Stocco, Yolanna Lu, Tod E Kippin, Kevin W Plaxco iD

Journal of the American Chemical Society · 11.03.2026 · 148 (9) · 10016-10025

DOI: 10.1021/jacs.5c22605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 26.02.2026. Verfasst von Kon Son und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Collaborative Biotechnologies, UCSB, Santa Barbara, California 93106, United States. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Electrochemical Techniques, Biosensing Techniques. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to monitor drug and biomarker concentrations in the body continuously and in real time could transform our understanding of physiology, enhance the diagnosis and monitoring of disease, and enable high-precision, truly personalized drug dosing. Toward this goal, we are developing electrochemical aptamer-based (EAB) sensors, the only real-time monitoring technology yet shown able to measure molecules as diverse as small molecule drugs to protein biomarkers in situ in the veins, brains, and peripheral tissues of live subjects. This advance notwithstanding, a significant challenge nevertheless remains: to date, degradation of their target-recognizing aptamer has limited the demonstrated, in vivo operation of EAB sensors to less than 24 h, reducing the platform's clinical and scientific utility. Notably, for example, the continuous glucose monitor did not come into widespread clinical use until it reached an in vivo duration of 5 days, with current models achieving an operational duration of 2 weeks. Thus motivated, here we use a non-natural, more nuclease-resistant "xenonucleic" acid (XNA) aptamer to extend the continuous, in vivo operation of EAB sensors to 1 week, with the latter encompassing >47,000 real-time, 12.8 s-resolved measurements. Moreover, we have reached this operational duration without employing protective membranes, which can harm sensor performance and complicate sensor fabrication and insertion. The week-long in vivo operation demonstrated here represents a crucial milestone for clinical adoption and experimental flexibility, marking a shift from short-term testing toward robust, long-duration, real-time molecular measurements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideElectrochemical TechniquesBiosensing TechniquesHumansTime Factors

Substanzen

Aptamers, Nucleotide

Autor:innen und Institutionen

  • Institute for Collaborative Biotechnologies, UCSB, Santa Barbara, California 93106, United States.
  • Interdepartmental Program in Quantitative Biology, UCSB, Santa Barbara, California 93106, United States.
  • Department of Psychological and Brain Sciences, UCSB, Santa Barbara, California 93106, United States.
  • Department of Chemistry and Biochemistry, UCSB, Santa Barbara, California 93106, United States.
  • Department of Bioengineering, UCSB, Santa Barbara, California 93106, United States.

ORCID-Profile: Kevin W Plaxco

Förderung

  • NIBIB NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Son, K., Gibson, J. M., Gerson, J., Leung, K. K., Stocco, M., Lu, Y., Kippin, T. E., & Plaxco, K. W. (2026). Continuous, Week-Long, Seconds-Resolved In Vivo Drug Measurements Performed with a Xenonucleic Acid-Employing Electrochemical, Aptamer-Based Sensor. Journal of the American Chemical Society, 148(9), 10016-10025. https://doi.org/10.1021/jacs.5c22605

Vancouver

Son K, Gibson JM, Gerson J, Leung KK, Stocco M, Lu Y, et al. Continuous, Week-Long, Seconds-Resolved In Vivo Drug Measurements Performed with a Xenonucleic Acid-Employing Electrochemical, Aptamer-Based Sensor. Journal of the American Chemical Society. 2026;148(9):10016-10025. doi:10.1021/jacs.5c22605

BibTeX
@article{Son2026,
  author = {Son, Kon and Gibson, Jennifer M and Gerson, Julian and Leung, Kaylyn K and Stocco, Marlaina and Lu, Yolanna and Kippin, Tod E and Plaxco, Kevin W},
  title = {Continuous, Week-Long, Seconds-Resolved In Vivo Drug Measurements Performed with a Xenonucleic Acid-Employing Electrochemical, Aptamer-Based Sensor},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {9},
  pages = {10016--10025},
  doi = {10.1021/jacs.5c22605}
}
Kostenlos starten →